Fulcrum therapeutics to participate in the stifel healthcare conference

Cambridge, mass., nov. 12, 2024 (globe newswire) -- fulcrum therapeutics, inc. (the “company”) (nasdaq: fulc), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that management will participate in a fireside chat at the stifel healthcare conference in new york city on november 19th at 3:35 pm et. management will also participate in one-on-one investor meetings.
FULC Ratings Summary
FULC Quant Ranking